These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8333228

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The management of postthrombolysis patients].
    Branzi A, Melandri G, Galié N.
    Cardiologia; 1991 Dec; 36(12 Suppl 1):413-9. PubMed ID: 1688159
    [Abstract] [Full Text] [Related]

  • 3. [The possible limits of thrombolysis: reocclusion and reperfusion damage].
    Ambrosio G, Golino P, Chiariello M.
    Cardiologia; 1991 Dec; 36(12 Suppl 1):421-33. PubMed ID: 1841798
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adjunctive therapy in thrombolysis for acute myocardial infarction.
    Bleich SD, Rolston WA, Tilton GD, Mailander L.
    Z Kardiol; 1993 Dec; 82 Suppl 2():179-82. PubMed ID: 8328199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombolysis in acute myocardial infarction.
    Chesebro JH, Holmes DR, Mock MB, Gersh BG, Fuster V.
    Cardiol Clin; 1988 Feb; 6(1):119-37. PubMed ID: 2971440
    [Abstract] [Full Text] [Related]

  • 10. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
    van den Bergh PJ, Kievit PC, Brouwer MA, Aengevaeren WR, Veen G, Verheugt FW.
    Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of reocclusion after coronary thrombolysis.
    Eisenberg PR.
    Z Kardiol; 1993 Mar; 82 Suppl 2():175-8. PubMed ID: 8328198
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D, Lijnen HR.
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [Abstract] [Full Text] [Related]

  • 13. Prevention of early reocclusion after thrombolysis of copper coil-induced thrombi in the canine carotid artery: comparison of PEG-hirudin and unfractionated heparin.
    Rübsamen K, Hornberger W.
    Thromb Haemost; 1996 Jul; 76(1):105-10. PubMed ID: 8819261
    [Abstract] [Full Text] [Related]

  • 14. [Role of antithrombotic agents after myocardial infarction].
    Castaigne A, Albo C, Verschuren P, Perchet H, Pham I, Saal JP.
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1703-8. PubMed ID: 1304143
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of platelets and thrombin: implications for treatment of coronary artery thrombosis.
    Runge MS, Bode C.
    Z Kardiol; 1993 Nov; 82 Suppl 2():83-8. PubMed ID: 8328214
    [Abstract] [Full Text] [Related]

  • 16. [The future of fibrinolysis: from fibrinolytic treatment to reperfusion therapy].
    Théroux P.
    Rev Esp Cardiol; 1992 Nov; 45 Suppl 2():84-90. PubMed ID: 1475513
    [Abstract] [Full Text] [Related]

  • 17. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
    Roux SP, Tschopp TB, Kuhn H, Steiner B, Hadváry P.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):501-8. PubMed ID: 8423548
    [Abstract] [Full Text] [Related]

  • 18. Dynamics of coronary thrombolysis and reocclusion.
    Becker R.
    Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III2-5. PubMed ID: 9422855
    [Abstract] [Full Text] [Related]

  • 19. [Prescription of heparin in the acute phase of myocardial infarction: expected and observed benefits...].
    Cador R, Weber S.
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1479-84. PubMed ID: 9092406
    [Abstract] [Full Text] [Related]

  • 20. Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.
    Lefkovits J, Malycky JL, Rao JS, Hart CE, Plow EF, Topol EJ, Nicolini FA.
    J Am Coll Cardiol; 1996 Dec; 28(7):1858-65. PubMed ID: 8962577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.